Revolve Biotechnologies Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Revolve Biotechnologies General Information

Description

Developer of a protein and nucleic acid evolution technology designed to produce custom DNA libraries. The company's platform develops an ultra-affinity antibody discovery engine and has a pipeline of protein products in development, enabling healthcare researchers to create high-affinity antibodies for diagnostic and therapeutic applications, oncolytic cancer therapeutics, and infrared fluorescent proteins for live deep-tissue imaging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 1100 Wicomico Street
  • Suite 323
  • Baltimore, MD 21230
  • United States
+1 (410) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revolve Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 29-Sep-2020 0000 Completed Generating Revenue
4. Grant 24-Aug-2015 00000 Completed Startup
3. Grant 07-Jan-2015 00000 Completed Startup
2. Grant 01-Jul-2013 $100K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Revolve Biotechnologies’s complete valuation and funding history, request access »

Revolve Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revolve Biotechnologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Civilization Ventures Venture Capital Minority 000 0000 000000 0
The Innovation Space Accelerator/Incubator Minority 000 0000 000000 0
National Institute of Mental Health Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
Maryland Innovation Initiative Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Revolve Biotechnologies FAQs

  • When was Revolve Biotechnologies founded?

    Revolve Biotechnologies was founded in 2013.

  • Who is the founder of Revolve Biotechnologies?

    Barrett Steinberg Ph.D, Elad Firnberg Ph.D, and Nirav Shelat Ph.D are the founders of Revolve Biotechnologies.

  • Where is Revolve Biotechnologies headquartered?

    Revolve Biotechnologies is headquartered in Baltimore, MD.

  • What is the size of Revolve Biotechnologies?

    Revolve Biotechnologies has 2 total employees.

  • What industry is Revolve Biotechnologies in?

    Revolve Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Revolve Biotechnologies a private or public company?

    Revolve Biotechnologies is a Private company.

  • What is Revolve Biotechnologies’s current revenue?

    The current revenue for Revolve Biotechnologies is 000000.

  • How much funding has Revolve Biotechnologies raised over time?

    Revolve Biotechnologies has raised $60K.

  • Who are Revolve Biotechnologies’s investors?

    Civilization Ventures, The Innovation Space, National Institute of Mental Health, TEDCO, and Maryland Innovation Initiative are 5 of 6 investors who have invested in Revolve Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »